Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Improving therapeutic strategies for extensive-stage small cell lung cancer (ES-SCLC) remains a challenge. To date, no reports have directly compared the efficacy and safety of immune checkpoint inhibitors plus platinum–etoposide (ICIs+EP) with platinum–irinotecan (IP) or directly compared different...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Koichi, Manabe, Ryo, Kishino, Yasunari, Kusumoto, Sojiro, Yamaoka, Toshimitsu, Tanaka, Akihiko, Ohmori, Tohru, Ohnishi, Tsukasa, Sagara, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025754/
https://www.ncbi.nlm.nih.gov/pubmed/33673470
http://dx.doi.org/10.3390/curroncol28020106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025754/
https://www.ncbi.nlm.nih.gov/pubmed/33673470
http://dx.doi.org/10.3390/curroncol28020106

Ejemplares similares